Fact CheckerSign in

NCT07739745Not yet recruiting

Development Of An Endometrial Cancer Educational Tool

Source: ClinicalTrials.gov · Last updated 31 Jul 2026

Brief summary (registry, in English)

The goal of this study is to develop an online educational tool that we can make widely available to broader patient community.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
250 (estimated)
First submitted
28 Jul 2026
Start date
1 Jan 2027
Primary completion date
1 Jun 2030
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT07739745

What you commit to

  • Study type: Interventional
  • Planned participants: 250
  • From 1 Jan 2027 to the primary completion date, 1 Jun 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Patients:
  • Study Objective 1 (Part A-C see Figure 2)
  • Women who have been diagnosed with endometrial cancer
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent
    • Study Objectives 2 and 3 (Pilot Study)
  • Women who have been diagnosed with endometrial cancer who are or will be receiving systemic treatment
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent.
    • Physicians:
    • Study Objective 1 (Qualitative Interviews)
  • Gynecologic oncologists or medical oncologists who practice at MDA or outside institutions
  • Must be able to speak and read English
  • Must provide written informed consent
    • Healthcare Providers:
    • Study Objectives 2 and 3 (Pilot Study)
  • Healthcare Providers (including but not limited to gynecologic oncologists and APPs) who practice at MDA, the HALs or LBJ Hospital who provide care to women diagnosed with endometrial cancer
  • Must be able to speak and read English
  • Must provide written informed consent

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UT MD Anderson
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.